PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
January 19, 2012 | ISSUE NUMBER 234 VOL 8

Sales Force
Sales Rep vs. eDetail: Consider the Practice Area
Forget illegal immigrants—machines are truly stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep predecessors have stepped out, according to a survey of U.S. physicians ...Read More

Investment
U.S. Strong, Europe Waning in Life Sciences Investment
A newly released report from Jones Lang LaSalle comparing world life sciences investment rankings between 2003–2006 and 2007–2010 show the U.S. at No. 1, with Ireland, China, and Singapore also in the top 5 in both analyses. But the report also revealed some important changes ...Read More

Lifestyle Trends
Close to Home: Is Good Health Communicable
The 2011 Edelman Health Barometer suggests that—in the same way that we spread colds, diseases, and other illnesses from person to person—good health and healthy behaviors can also be spread. Can pharma play a pivotal role in the good-health epidemic? ...Read More

Regulatory
Generic and Biosimilar User Fees Gain Traction
FDA has issued recommendations for three user-fee programs: the fifth authorization of the Prescription Drug User Fee Act and new user-fee programs for human generic drugs and biosimilar biological products ...Read more

Ad Stars 2012
Call for Entries
It’s that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We’d like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more information

// Algeta (Oslo, Norway) announced the appointment of Jeffrey W. Albers as President of Algeta U.S., the company’s new U.S. commercial operation. // David Elder, former Director of the Office of Regional Operations (ORO) within the FDA’s Office of Regulatory Affairs, was appointed as a Vice President to its Strategic Compliance Services team for Parexel. // OPTIMIZERx (Sample, MD) moved headquarters to Rochester, Mich., and hired Patrick Fennimore as Vice President of Sales (East), Sudhakar Suruvu as Director of Technical Development, and Raj Nalla to Director of Software Development. Terry Hamilton was also promoted to Senior Vice President of Sales.
// David Riding was named Vice President, Client Services for the StemScientific division of KnowledgePoint360 Group (Lyndhurst, NJ). Michael Friedin also became the company’s Vice President of eMedFusion. // Roska Healthcare Advertising (Montgomeryville, PA) hired Anupam singh in the newly created position as Vice President, Integrated Strategy.

Jan. 24–25: CBI's 9th Annual Compliance Congress
Washington, DC


Feb. 16–17: Pharma Strategy and Business Innovation Conference
Cancun, Mexico


Feb. 28–29: Global Transparency Congress
London, UK



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook


Survey
In your opinion, how likely is it that pharma and biotech companies will continue to increase their outsourcing of clinical trials and related drug development in the next five years?

Click To Vote
 
Quick Links

Last week's JP Morgan Healthcare Conference Marked by Uncertainty

GSK in Spotlight for 'Unethical Trials'

BMS to Acquire Inhibitex for $2.5 Billion


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive